London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Phacoemulsification in a patient with intralenticular dexamethasone implant

Poster Details

First Author: A.Akman TURKEY

Co Author(s):    S. Gür Güngör   Y. Güneş           

Abstract Details


To report a patient who underwent inadvertent injection of dexamethasone implant into the crystalline lens.


Baskent University Hospital, Ankara, Turkey.


Case Report. A 69-year-old man presenting with visual loss in the right eye was diagnosed as macular edema due to branch retinal vein occlusion. On presentation, the visual acuity was 20/100 in the right eye and 20/20 in the left eye. Intraocular pressure (IOP) was 14 mm Hg in the right eye and 16 mm Hg in the left eye. Dexamethasone implant was injected inadvertently into the crystalline lens. Slit lamp examination showed the implant had penetrated the posterior lens capsule and was lodged in the posterior cortex of the lens; a posterior cortical cataract developed subsequently. The visual acuity decreased to 20/200 in the right eye.


A decision was made to perform phacoemulsification with intraocular lens (IOL) implantation and reposition the dexamethasone implant in the vitreous cavity to preserve the therapeutic effect of the implant. The IOL was fixated in the sulcus. On the first postoperative week, the IOL was well-centered, the anterior segment was quiet, and the best corrected visual acuity was 20/100.


Ophthalmologists should be aware for the intravitreal dexamethasone implant to damage or rupture the posterior capsule of the lens. This report illustrates the efficacy of the repositioning technique in our case of intralenticular dexamethasone implant injection. FINANCIAL INTEREST: NONE

Back to Poster listing